MedTrace Logo

Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte

NCT01627158 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2012-10-15

No results posted yet for this study

Summary

The purpose of this study is to compare the test product Budesonide/formoterol Easyhaler with the marketed product Symbicort Turbuhaler in terms of the drug absorbed into the bloodstream.

Conditions

Interventions

DRUG

Budesonide/formoterol Easyhaler

Budesonide/formoterol Easyhaler

DRUG

Symbicort Turbuhaler

Symbicort Turbuhaler

DRUG

Charcoal and Budesonide/formoterol Easyhaler

Charcoal and Budesonide/formoterol Easyhaler

DRUG

Charcoal and Symbicort Turbuhaler

Charcoal and Symbicort Turbuhaler

Sponsors & Collaborators

  • Orion Corporation, Orion Pharma

    lead INDUSTRY

Principal Investigators

  • Irja Korpela, MSc · Orion Corporation, Orion Pharma

  • Rainard Fuhr, Dr. med. · Parexel Berlin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01627158 on ClinicalTrials.gov